Difference between revisions of "COVID-19 Testing"
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
[https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html "The CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay is a real-time reverse-transcriptase polymerase chain reaction (RT-PCR) test that detects and differentiates RNA from SARS-CoV-2, influenza A virus, and influenza B virus in upper or lower respiratory specimens. The assay provides a sensitive, nucleic-acid-based diagnostic tool for evaluation of specimens from patients in the acute phase of infection."] | [https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html "The CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay is a real-time reverse-transcriptase polymerase chain reaction (RT-PCR) test that detects and differentiates RNA from SARS-CoV-2, influenza A virus, and influenza B virus in upper or lower respiratory specimens. The assay provides a sensitive, nucleic-acid-based diagnostic tool for evaluation of specimens from patients in the acute phase of infection."] | ||
| + | |||
Additionally, the following is posted at the same webpage... | Additionally, the following is posted at the same webpage... | ||
[[https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html "The U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for this test on July 2, 2020. Test kits are in production and will be shipped to public health laboratories once production, including quality control and assembly, has been completed."] | [[https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html "The U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for this test on July 2, 2020. Test kits are in production and will be shipped to public health laboratories once production, including quality control and assembly, has been completed."] | ||
Revision as of 15:38, 14 July 2020
From the CDC Webpage...
Additionally, the following is posted at the same webpage...